Anna Chin

440 citations
8 papers · 291 · 1 hit paper · h-index 6

Impact in

Papers in

Anna Chin

8 papers receiving 289 citations

Hit Papers

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele 2023 · 74 citations
740+1+2Years since publication204060

Peers

Anna Chin
Comparison fields: 5 of 45
  • Pulmonary and Respiratory Medicine 197
  • Gastroenterology 31
  • Emergency Medical Services 12
  • Cell Biology 24
  • Oncology 38
Replace Fouad Otaki with:
Fouad Otaki United States
James Markowitz United States
Marwa Abu El Haija United States
Zaichun Deng China
Yongdong Wu China
P. Sipponen Finland
H. Schäfer Germany
Yukinori Nakae Japan
Tetsuya Nakazato Japan
Tomokazu Nunoue Japan
Anna Chin relative to Fouad Otaki United States Fouad Otaki's profile →
Citations per field
00.5×
Fouad Otaki · 1×
Citations per year

Countries citing papers authored by Anna Chin

Since Specialization
Citations

This map shows the geographic impact of Anna Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Chin more than expected).

Fields of papers citing papers by Anna Chin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Chin. The network helps show where Anna Chin may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Chin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Chin Line = papers co-authored together Anna Chin links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele
Hit paper breakdown →
202374
2 202366
3 200746
4 200835
5 200934
6 202334
7 20241
8 20251

About Anna Chin

Anna Chin is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 8 papers that have together received 291 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (5 papers), Tracheal and airway disorders (3 papers), Neonatal Respiratory Health Research (2 papers), Genetic factors in colorectal cancer (1 paper), Cancer therapeutics and mechanisms (1 paper), Neurofibromatosis and Schwannoma Cases (1 paper), DNA Repair Mechanisms (1 paper) and Genomics and Chromatin Dynamics (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (197 citations), Gastroenterology (31 citations), Emergency Medical Services (12 citations), Cell Biology (24 citations) and Oncology (38 citations). Anna Chin has collaborated with scholars based in United States, Australia and Ireland. Frequent co-authors include Stefan Duensing, Anette Duensing, Tanya G. Weinstock, Neil Ahluwalia, Joshua A. Parry, Shih–Fan Kuan, Linan Wang, Julie K. Bower, Nataliya Volkova and Fengjuan Xuan. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Cystic Fibrosis, Virology, Molecular Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact